CureDuchenne
3334 East Coast Hwy 157
Corona del Mar
California
92625
United States
Tel: 949-721-4063
Fax: 949-760-1030
Website: http://www.cureduchenne.org/
Email: help@cureduchenne.org
72 articles about CureDuchenne
-
Anaheim Ducks Captain Ryan Getzlaf Supports CureDuchenne In 7th Annual Getzlaf Golf Shootout To Help Saves Lives Of Those With Duchenne
5/2/2017
-
Leader In Cure, Care And Community For Duchenne Muscular Dystrophy CureDuchenne Launches New Website
3/28/2017
-
Eighth Annual Champions To CureDuchenne Gala Presented By Fired Up Charity Foundation To Be Held April 8 At University of Texas Golf Club
3/22/2017
-
BioMarin Release: Biotech Transfers Duchenne Natural History Database To CureDuchenneTo Improve Knowledge Of Duchenne Patients And Improve Clinical Outcomes
1/10/2017
-
CureDuchenne Release: Non-Profits, Pharmaceutical Companies And Noted Clinicians Collaborate To Launch The Collaborative Trajectory Analysis Project (Ctap); Advancing Clinical Trial Design For Duchenne Muscular Dystrophy
10/25/2016
-
CureDuchenne's Early Stage Investment In Bamboo Therapeutics Accelerates Gene Therapy For Duchenne, Bamboo Acquired By Pfizer
8/1/2016
-
CureDuchenne And Catabasis To Host A Webinar To Review Information On Edasalonexent (CAT-1004) And The MoveDMD Trial On June 22, 2016
6/14/2016
-
Bamboo Therapeutics And CureDuchenne To Host A Webinar On Developing Gene Therapy For Duchenne Muscular Dystrophy On June 13, 2016
6/2/2016
-
CureDuchenne Responds To FDA Decision On Drisapersen For Duchenne Muscular Dystrophy
1/14/2016
-
Capricor Therapeutics, Inc. And CureDuchenne To Host Webinar On November 3, 2015 At 3:00 p.m. ET
10/30/2015
-
CureDuchenne’s Funding Bears Fruit With Drisapersen: First-Ever New Drug Application (NDA) Accepted By FDA For Duchenne Muscular Dystrophy
6/29/2015
-
Capricor Therapeutics, Inc. And CureDuchenne To Host Webinar On June 19, 2015 At 3:00 P.M. ET
6/15/2015
-
CureDuchenne Celebrates Submission Of First-Ever New Drug Application For Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping; Cureduchenne Was Early Funder Of Drisapersen’s Development
4/27/2015
-
Capricor Therapeutics, Inc. And CureDuchenne To Host Webinar On January 21, 2015 At 3:00 P.M. ET
1/21/2015
-
CureDuchenne Seeds Collaborative Project To Analyze The Natural History Of Duchenne Muscular Dystrophy
1/13/2015
-
ProSensa Holding N.V. And CureDuchenne Strengthen Long-Term Collaboration With An Additional [Eur]5M To Advance DMD Pipeline
8/12/2014
-
CureDuchenne Media Statement Regarding ProSensa Holding N.V. Announcement Of Regulatory Path Forward For Drisapersen As A Potential Treatment For DMD
6/3/2014
-
CureDuchenne Release: “CureDuchenne Ventures” Launched to Accelerate Drug Discovery and Development for Duchenne Muscular Dystrophy
9/26/2013
-
CureDuchenne to Host Drug Development and Clinical Trial Participation – A Webinar for the Rare Disease Community on September 13
9/10/2013
-
Statement From CureDuchenne Regarding ProSensa B.V. IPO
6/28/2013